Developer of novel peptide-based therapies intended to address unmet medical needs of psychiatric conditions within the spectrum of depressive and anxiety disorders. The company's therapy helps to identify an unknown family of peptides with biological activity in anxiety and depression, by means of proprietary processing of whey and casein from bovine's milk, enabling baby food manufacturers to reduces the risk of the motor mental retardation through their food product.
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
1. Accelerator/Incubator | 01-Apr-2012 | Completed | Pre-Clinical Trials |
Name | Title | Board Seat | Contact Info |
---|---|---|---|
Askar Kuchumov Ph.D | Chief Executive Officer | ||
Igor Doronin | Co-Founder & Director of PD | ||
Anton Malyshev | Co-Founder & CSO | ||
Gennady Babkin | Co-Founder |
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
MSU Business Incubator | Accelerator/Incubator | Minority | 000 0000 | 000000 0 |